Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2023-01-26 00:00:00 ET · period of report 2023-01-24 · accession 0001209191-23-005032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-26 | 2023-01-24 | TVTX | Cline Christopher R. | CFO | S - Sale | $21.90 | -852 | 32.9K | -3% | -$18.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-24 | S | D | 852 | $21.90 | 32,871 | D | — | — |